The objectives of the study were to assess the utility of CEA, CRP, serum albumin level, hemoglobin, and LDH as biomarkers of cancer risk and the biological implications of diabetes on the evolution and prognosis of oncological patients. Here, CEACAM5 is linked to diabetes mellitus.